Free Webex Call
The Malaysia Cardiovascular Devices Market was valued at USD 4.14 Billion in 2024, and is projected to reach USD 5.84 Billion by 2030, rising at a CAGR of 5.90%. The cardiovascular devices market in Malaysia has witnessed significant growth over the past few years, owing to the increasing adoption of sedentary lifestyles and unhealthy diets in the country. Cardiovascular diseases (CVDs) continue to be a major health concern in Malaysia, with a significant number of people affected each year. It has been reported that cardiovascular disease cases increase by 5% every year in Malaysia. Sedentary lifestyles refer to a lack of physical activity, which can be a result of a variety of factors such as long working hours, increased use of technology, and the availability of modern conveniences. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
In Malaysia, many people lead sedentary lifestyles due to long commutes, desk-bound jobs, and a lack of access to recreational facilities. This lack of physical activity can lead to a variety of health problems, including obesity (according to the National Health and Morbidity Survey (NHMS) 2019, Malaysia’s obesity rate amongst 18 years and above is reported to be 19.7%), hypertension (approximately 30% of Malaysians aged 18 years and above are affected from hypertension, according to the Malaysian National Health and Morbidity Survey 2019), and diabetes (the diabetes prevalence in Malaysia ranges from 7.3% to 23.8%, according to published reports), which are all risk factors for CVDs.
Key Market Drivers
High Prevalence of Cardiovascular Diseases
Cardiovascular disease (CVD) has consistently accounted for nearly 23.3% of all deaths in Malaysia for many years, according to Health Minister Datuk Seri Dr Dzulkefly Ahmad. High cholesterol is a major risk factor for atherosclerotic CVD, a leading cause of morbidity and mortality. The 2023 National Health and Morbidity Survey revealed that 33.3% of adults in Malaysia, or 7.6 million people aged 18 and above, suffer from high cholesterol. More worryingly, one in two adults with high cholesterol don't even know they have it because increased cholesterol levels often don't have symptoms. Despite treatment, the challenge has always been there; the control of cholesterol levels is still not at target for many patients, especially those with high risk.Key Market Challenges
High Costs Associated with Advanced Cardiovascular Devices
Devices like pacemakers, defibrillators, and transcatheter valves can be costly, impacting accessibility, especially in low-income regions. In Malaysia, high device costs may limit adoption, particularly in budget-constrained healthcare settings. The financial burden associated with these advanced devices poses a significant barrier to their widespread implementation, potentially leading to disparities in the quality of cardiovascular care across different socioeconomic groups.Key Market Trends
Growth in Wearable and Home-Based Monitoring Devices
Wearable ECGs, smartwatches with heart rate monitoring, and remote monitoring devices allow patients to track their heart health at home. In Malaysia, demand for wearable monitoring devices is increasing as patients seek convenient, accessible healthcare solutions. These devices empower patients to take a proactive role in managing their heart health, leading to early detection of potential issues and timely medical intervention. The integration of such technologies into patient care aligns with the global shift towards personalized and preventive healthcare.Key Market Players
- B. Braun Medical Supplies Sdn Bhd
- Abbott Medical Malaysia Sdn Bhd
- LivaNova Malaysia SDN BHD
- Edwards Lifesciences (M) Sdn Bhd
- GE Healthcare
- BIOTRONIK Medical Devices (Malaysia) SDN BHD
- Terumo Malaysia Sdn. Bhd.
- FUJIFILM Malaysia Sdn. Bhd.
- Philips Malaysia Sdn Bhd
Report Scope:
In this report, Malaysia cardiovascular devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Malaysia Cardiovascular Devices Market, By Type:
- Diagnostic & Monitoring Devices
- Surgical Devices
Malaysia Cardiovascular Devices Market, By Application:
- Coronary Artery Disease
- Cardiac Arrhythmia
- Heart Failure
- Others
Malaysia Cardiovascular Devices Market, By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Others
Malaysia Cardiovascular Devices Market, By Source:
- Import
- Domestic
Malaysia Cardiovascular Devices Market, By Region:
- West Malaysia
- East Malaysia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Malaysia cardiovascular devices market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Malaysia Cardiovascular Devices Market Outlook
6. East Malaysia Cardiovascular Devices Market Outlook
7. West Malaysia Cardiovascular Devices Market Outlook
8. Market Dynamics
9. Market Trends & Developments
13. Porter’s Five Forces Analysis
15. Competitive Landscape
Companies Mentioned
The leading companies profiled in this Malaysia Cardiovascular Devices market report include:- B. Braun Medical Supplies Sdn Bhd
- Abbott Medical Malaysia Sdn Bhd
- LivaNova Malaysia SDN BHD
- Edwards Lifesciences (M) Sdn Bhd
- GE Healthcare
- BIOTRONIK Medical Devices (Malaysia) SDN BHD
- Terumo Malaysia Sdn. Bhd.
- FUJIFILM Malaysia Sdn. Bhd.
- Philips Malaysia Sdn Bhd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 85 |
Published | September 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 4.14 Billion |
Forecasted Market Value ( USD | $ 5.84 Billion |
Compound Annual Growth Rate | 5.9% |
Regions Covered | Malaysia |
No. of Companies Mentioned | 10 |